Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acuity Medical
Electrical stimulation device treats age-related macular degeneration
November 4th, 2005
Acuity Medical is pursuing new electrical stimulation technology to treat dry age-related macular degeneration (AMD), the leading cause of vision loss and legal blindness in adults over 60 in the U.S. Currently there is no effective treatment for AMD which, according to the World Health Organization, affects more than 50 million people worldwide. Dry macular degeneration is the most common form of AMD, representing approximately 90% of all macular degeneration cases. Less common but more severe is wet AMD. There is no generally accepted treatment for dry macular degeneration, although vitamins, antioxidants and zinc supplements may slow its...
Source: Biotech Law Weekly (2005-11-04)
|
